Abstract
Creation of clinical practice guideline of multiple endocrine neolasiagland (MEN) in our country was the first target of the MEN consortium established in 2008.
From 2009, the Ministry of Health, Labour and Welfare Grant-in-Aid-for-Scientific-Research (Intractable Disease Research Program)“ creation of clinical guideline of MEN 1 type and 2 types” research group in which Dr. Sakurai is a research representative was inaugurated.
Moreover, the MEN consortium has obtained support also from a Japanese Society of Thyroid Surgery, the Japan Association of Endocrine Surgeons and the Japanese Society for Familial Tumor.
Furthermore, it was adopted also as the clinical important problem of the Japan Endocrine Society, group research also became the 3rd year, and it was required that a clinical practice guideline should have been created immediately.
The assignment writer and the assignment writing cooperator were determined as the main item creation of this guideline, Clinical Question (CQ) was created per each item in its duty, and examination was started.
CQ, the determination of a proposal, selection of the column, etc. were worked.
Determined CQ, columns are 56, 10 in MEN1 and 44, 17 in MEN2, respectively.
The recommendation grade based on evidence is due to search literature for every after that CQ proposal, to create a structured abstract, and to be determined from now on.
It is thought that completion of this guideline brings a big benefit to what is engaged in the MEN medical examination and research in Japan.
